Follow CBSPHILLY Facebook Twitter

PHILADELPHIA (CBS) — The Food and Drug Administration (FDA) is taking heat for approving a powerful, fast-acting opioid.

Study: Spanking Is Linked to Dating Violence Later In Life

Dsuvia is 10 times more powerful than fentanyl. It’s an alternative to IV painkillers used in hospitals.

Critics are blasting the FDA for approving Dsuvia as the country faces increasing opioid overdose deaths.

Credit:Roberto Machado Noa/LightRocket via Getty Images

“Recognizing the drug’s population-based risks, there are strong limits on its use. It can’t be dispensed to patients for home use and should not be used for more than 72 hours, and it will only be administered by a certified health care provider using a single-dose applicator,” FDA Commissioner Dr. Scott Gottlieb tweeted Sunday.

First All Survivors Day Aims To Empower Sexual Assault Survivors To Speak Up, Speak Out

The FDA insists it’s managing the opioid crisis and the new drug is needed by patients to manage pain.